Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
NCT07548632

A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

Led by Oculis · Updated on 2026-05-05

160

Participants Needed

10

Research Sites

32 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.

CONDITIONS

Official Title

A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Physician diagnosis of Dry Eye Disease in the past 6 months
  • Use of over-the-counter tears
  • Must agree to genotype testing
Not Eligible

You will not qualify if you...

  • Any disorder or condition that might interfere with study results or participant safety, as judged by the Investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 10 locations

1

Global Research Management

Glendale, California, United States, 91204

Actively Recruiting

2

Eye Research Foundation

Newport Beach, California, United States, 92664

Actively Recruiting

3

Vision Institute

Colorado Springs, Colorado, United States, 80907

Actively Recruiting

4

Segal Drug Trials, Inc.

Delray Beach, Florida, United States, 33484

Not Yet Recruiting

5

Oculus Research, Inc.

Garner, North Carolina, United States, 27529

Actively Recruiting

6

CORE, Inc

Shelby, North Carolina, United States, 28150

Not Yet Recruiting

7

Scott & Christie and Associates

Cranberry Township, Pennsylvania, United States, 16066

Actively Recruiting

8

Erie Retina Research

Erie, Pennsylvania, United States, 16507

Not Yet Recruiting

9

Total Eye Care, PA

Memphis, Tennessee, United States, 38119

Actively Recruiting

10

Piedmont Eye Center, Inc.

Lynchburg, Virginia, United States, 24502

Actively Recruiting

Loading map...

Research Team

O

Oculis Chief Development Officer

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here